Early trial tests cholesterol pill to boost leukemia fight
NCT ID NCT04512105
Summary
This early-stage study tested the safety of adding a common cholesterol-lowering drug (pitavastatin) to a standard leukemia treatment (venetoclax). It involved 6 adults with either chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML). The main goal was to find the safest dose and see if the drug combination could help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chao Family Comprehensive Cancer Center, University of California, Irvine
Orange, California, 92868, United States
Conditions
Explore the condition pages connected to this study.